Trial Profile
A prospective efficacy and safety study of a novel antiretroviral regimen comprising of Etravirine and Raltegravir in HIV infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Sep 2015
Price :
$35
*
At a glance
- Drugs Etravirine (Primary) ; Raltegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 09 Sep 2015 New trial record